Dr. Rebecca Brachman is a pioneer in the field of preventative psychopharmacology, developing drugs to enhance stress resilience and prevent mental illness.
Current treatments for mood disorders only suppress symptoms without addressing the underlying disease, and there are no known cures. The drugs Dr. Rebecca Brachman is developing would be the first to prevent psychiatric disorders such as post-traumatic stress disorder (PTSD) and depression.
BrainMind is a platform and private community of top brain scientists, entrepreneurs, investors, philanthropists, and academic institutions collaborating to accelerate impactful innovation in brain science.
Apply to become a member of the BrainMind ecosystem: